Director, Revenue Accounting and Finance

Revolution Medicines

2d•$201,000 - $251,000•Onsite

About The Position

Revolution Medicines is seeking a Director, Revenue Accounting and Finance to lead revenue accounting, gross-to-net accounting and forecasting, and related commercial finance activities as the company scales its commercial operations. Reporting to the Senior Director, Revenue Accounting and Finance, this role oversees financial close, forecasting, controls, government pricing coordination, analytics, and global revenue reporting. The Director will develop scalable methodologies, controls, and reporting capabilities while balancing operational execution with longer-term process development. The role serves as a senior Finance partner to Commercial, Market Access, Analytics & Insights, Corporate Accounting, FP&A, and regional Finance teams. It requires pharmaceutical revenue and gross-to-net expertise, sound technical accounting judgment, and the ability to lead cross-functional initiatives, influence business decisions, and turn commercial and market dynamics into actionable financial insights. This is a full-time position. The listed base pay salary range for candidates working onsite at the headquarters in Redwood City, California, is $201,000–$251,000 USD; the range is adjusted for local market and individual factors. The position’s total rewards program also includes competitive cash compensation, equity awards, benefits, and learning and development opportunities.

Requirements

Bachelor’s degree in Accounting, Finance, Economics, or a related field.
10+ years of progressive accounting, finance, or related experience, including significant pharmaceutical or biotechnology revenue accounting and gross-to-net experience.
Deep expertise in pharmaceutical revenue accounting, gross-to-net accounting and forecasting, including U.S. GAAP and ASC 606 for commercial revenue arrangements.
Strong understanding of pharmaceutical gross-to-net drivers, including rebates, chargebacks, discounts, returns, copay and patient assistance programs, government programs, distributor fees, and other variable consideration.
Demonstrated experience developing and evolving gross-to-net forecasting methodologies, analyzing forecast-versus-actual performance, and translating business and market dynamics into financial assumptions and recommendations.
Experience strengthening accounting processes, policies, and internal controls in a public company environment subject to SOX, SEC, and U.S. GAAP requirements.
Demonstrated ability to lead complex cross-functional initiatives and influence decisions across Commercial, Market Access, Analytics & Insights, FP&A, Accounting, and senior leadership.
Strong strategic and analytical judgment, including the ability to identify complex issues, develop practical solutions, and balance near-term execution with long-term scalability.
Experience working with external consultants and commercial partners and holding third parties accountable for accurate and timely deliverables.
Strong executive communication skills and ability to explain complex financial matters, risks, recommendations, and insights to senior leaders and non-Finance stakeholders.
Demonstrated interest in and experience using AI, automation, or advanced analytics to improve Finance processes and decision-making.
Advanced analytical skills and proficiency in Microsoft Excel, Word, and PowerPoint.

Nice To Haves

CPA or MBA.
Experience supporting a first commercial product launch or scaling Finance infrastructure at an early commercial-stage pharmaceutical or biotechnology company.
Experience operating across global or multi-regional commercial organizations and coordinating revenue reporting and forecasting across regional Finance teams.
Experience overseeing third-party government pricing, gross-to-net, contract analytics, or related commercial Finance vendors.
Experience with SEC reporting and revenue-related financial statement disclosures.
Experience implementing or improving revenue accounting, gross-to-net forecasting, analytics, reporting, or automation tools.

Responsibilities

Lead monthly product revenue and gross-to-net close activities, including calculation, review, and monitoring of accruals and reserve balances for discounts, assistance programs, returns, government programs, and other variable consideration.
Oversee revenue and gross-to-net accounting processes, including journal entries, reconciliations, flux analyses, reserve rollforwards, close schedules, and supporting documentation.
Strengthen revenue and gross-to-net controls, policies, and procedures to support SOX compliance, audit readiness, and commercial growth.
Develop and evolve gross-to-net forecasting models and methodologies for budgeting, forecasting, long-range planning, and scenario analysis.
Partner with Commercial and Market Access on gross-to-net assumptions, forecasts, performance trends, pricing and contracting considerations, and access strategies.
Partner with Analytics & Insights to incorporate demand, patient, payer, and market data into forecasts and analyses, translating trends into actionable insights.
Develop analytics and management reporting on gross sales, discounts, reserve adequacy, forecast accuracy, risks, and opportunities to inform senior leadership.
Oversee the external government pricing consultant relationship, including data submissions, review of calculations and outputs, issue resolution, and compliance support.
Drive adoption of approved AI-enabled tools, automation, and advanced analytics in accounting, forecasting, reconciliations, reporting, and close processes while maintaining governance, controls, auditability, and policy compliance.
Partner with the Senior Director, Revenue Accounting and Finance and the Vice President, Finance and Corporate Accounting on strategic initiatives, cross-functional matters, SEC disclosures, and significant accounting or forecasting decisions.
Lead headquarters coordination for global revenue and reporting with regional Finance and Accounting teams, establishing consistent inputs, methodologies, assumptions, controls, variance analysis, and consolidation-ready reporting.